Page 10 - Bharat Biotech

Serum chairman Cyrus Poonawalla against using cocktail of Covid vaccines

Serum Institute of India (SII) chairman Dr Cyrus Poonawalla on Friday said he was not in favour of administering two different coronavirus vaccines for better efficacy. Poonawalla, whose firm makes the Covishield vaccine, was speaking to reporters after receiving the Lokmanya Tilak National Award here. "I am against the mixing of two different vaccines. There is no need to mix two different vaccines," he said, when asked about a recent ICMR study that a cocktail of Covishield and Covaxin could generate better immunity. "If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results," Poonawalla said. The efficacy of this approach has not been proven in field trials involving thousands of participants, he added. A study by the Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently ...

Indian Immunologicals to make drug material for 10 mn Covaxin doses a month

IIL has repurposed its manufacturing unit in Hyderabad, procured key raw materials and consumables apart from equipment at 'breakneck' speed; production commenced in July

PSU receives loan license to supply Bharat Biotech's Covaxin drug substance

PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, DBT said on Friday

Bharat Biotech's intranasal vaccine gets regulator nod for Phase 2/3 trials

It is the first nasal vaccine in the country that has received the regulatory approval for late-stage clinical trials

Covid-19 pandemic: Bharat Biotech's Covaxin ready for dispatch at new plant

The doses are ready to be dispatched to the Central Drugs Laboratory in Kasauli for quality and sterility inspection this month

Mandaviya meets WHO chief scientist, discusses health body nod for Covaxin

Mandaviya on Thursday met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the global health body's approval for Bharat Biotech's COVID-19 vaccine Covaxin

Govt okays Bharat Biotech's Ankleshwar plant to produce Covaxin: Minister

Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin. "Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted. The approval would help increase availability of COVID-19 vaccines in the country, he added. "Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted. In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.

Mixing Covaxin and Covishield safe, gives better immune response: ICMR

The study was conducted on 18 individuals who inadvertently received Covishield as first jab and Covaxin as second in UP at a gap of six weeks

Covishield-Covaxin combination works better than 2 doses of same jab: ICMR

Study also found that the combination was safe and adverse effects were found to be similar when compared to the same-dose regimen

Supporting 3 PSUs, Bharat Biotech facility for more Covaxin doses: Govt

Facility augmentation of Bharat Biotech and three public sector enterprises is being supported for enhancing production of COVID-19 vaccine Covaxin, Parliament was informed on Friday. The Department of Biotechnology has informed that the facility augmentation of Bharat Biotech and 3 public sector enterprises (PSEs) Haffkine Biopharmaceutical Corporation Ltd, Indian Immunologicals Ltd; and Bharat Immunologicals Biologicals Corporation Ltd is being supported for augmented production of Covaxin, Minister of Health & Family Welfare and Chemicals & Fertilizers Mansukh Mandaviya said in a written reply to a question in the Rajya Sabha. This is being done under the 'Mission COVID Suraksha the Indian COVID-19 Vaccine Development Mission', he added. Further, technology transfer of Covaxin production to Gujarat COVID Vaccine Consortium comprising Hester Biosciences, OmniBRx Biotechnologies Pvt Ltd and Gujarat Biotechnology Research Centre is being facilitated by the Department of ..

Over 200 tests for every batch: Bharat Biotech on Covaxin quality concern

Each batch of the vaccine was subjected to more than 200 quality control tests at its facilities, followed by submission samples to CDL. Only based on approval by CDL are batches released commercially

Production of 1.35 bn vaccine doses between August, December a long haul

Covishield production to cross 120 mn doses a month, Covaxin 58 mn doses a month

Covaxin receives GMP certificate from Hungary, says Bharat Biotech

Bharat Biotech's Covid-19 vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary, the vaccine maker said on Thursday in a tweet

Indian Immunologicals may start supplying 2 mn Covaxin doses by Sep: Govt

NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups related to standardisation quality assurances of batches of vaccines at Bangalore plant, which delayed production

Bharat Biotech's Covaxin effective against Delta plus variant, says study

The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India

Bharat Biotech's Covaxin effective against Delta Plus variant: ICMR study

Bharat Biotech's Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study by the Indian Council of Medical and Research

Bharat Biotech's Rotavac 5D receives WHO Prequalification

Bharat Biotech on Monday announced that the World Health Organisation has awarded prequalification to its rotavirus vaccine,Rotavac 5D to prevent rotavirus diarrhea, the company said.

India may soon have Covid-19 vaccines for children. All you need to know

Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above

Expert panel recommends trials on mixing Covaxin and Covishield

As per sources, the application of the interchangeability study protocol of Covishield and Covaxin was moved by Christian Medical College (CMC) in Vellore.

Covid-19 vaccine for children likely in August: Health minister Mandaviya

Zydus Cadila has done trials on 12-plus; Bharat Biotech conducting trials on two-plus